{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:17:01Z","timestamp":1790777821940,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.lansea.2023.100256","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T06:56:52Z","timestamp":1692860212000},"page":"100256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial"],"prefix":"10.1016","volume":"19","author":[{"given":"Sanket","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan Kumar","family":"Nandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaily S.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhakti","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarang","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandramani","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Chayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek T.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya Khare","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Ok","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngran","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lansea.2023.100256_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010358","article-title":"Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: a modeling study","volume":"16","author":"Leung","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"10333","key":"10.1016\/j.lansea.2023.100256_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"Kanungo","year":"2022","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib5","doi-asserted-by":"crossref","first-page":"A184","DOI":"10.1016\/j.vaccine.2019.07.082","article-title":"Oral cholera vaccine delivery strategy in India: routine or campaign? -A scoping review","volume":"38","author":"Ray","year":"2020","journal-title":"Vaccine"},{"issue":"12 Suppl 2","key":"10.1016\/j.lansea.2023.100256_bib6","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1093\/infdis\/jiab465","article-title":"Challenges for programmatic implementation of oral cholera vaccine in India","volume":"224","author":"Chakraborty","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.lansea.2023.100256_bib7","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.3390\/ijerph19095738","article-title":"Cholera outbreaks in India, 2011-2020: a systematic review","volume":"19","author":"Muzembo","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"38 Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib8","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1016\/j.vaccine.2019.07.036","article-title":"Cholera surveillance and estimation of burden of cholera","volume":"29","author":"Ganesan","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib9","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2019.12.011","article-title":"Current and future cholera vaccines","volume":"38","author":"Shaikh","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib10","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013-2018","volume":"38","author":"Pezzoli","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lansea.2023.100256_bib11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib12","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1016\/j.vaccine.2020.01.016","article-title":"The history of OCV in India and barriers remaining to programmatic introduction","volume":"38","author":"Mogasale","year":"2020","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.lansea.2023.100256_bib13","doi-asserted-by":"crossref","first-page":"A127","DOI":"10.1016\/j.vaccine.2019.06.082","article-title":"Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: lessons learned and way forward","volume":"38","author":"Islam","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.lansea.2023.100256_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066945","article-title":"Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017\/2018 outbreak: a matched case-control study in Lusaka, Zambia","volume":"12","author":"Sialubanje","year":"2022","journal-title":"BMJ Open"},{"issue":"45","key":"10.1016\/j.lansea.2023.100256_bib15","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story \u2013 development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.lansea.2023.100256_bib16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/vaccines9121482","article-title":"Oral cholera vaccine efficacy and effectiveness","volume":"9","author":"Song","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.lansea.2023.100256_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/tropicalmed6020064","article-title":"An update on cholera immunity and current and future cholera vaccines","volume":"6","author":"Holmgren","year":"2021","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"10.1016\/j.lansea.2023.100256_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea [published correction appears in J Korean Med Sci. 2014 Aug;29(8):1182]","volume":"29","author":"Baik","year":"2014","journal-title":"J\u00a0Korean Med Sci"},{"issue":"46","key":"10.1016\/j.lansea.2023.100256_bib19","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A\u00a0randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.lansea.2023.100256_bib20","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/j.vaccine.2018.05.102","article-title":"A\u00a0randomized, observer-blinded, equivalence trial comparing two variations of Euvichol\u00ae, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines","volume":"36","author":"Russo","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lansea.2023.100256_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218033","article-title":"Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India","volume":"14","author":"Raghava Mohan","year":"2019","journal-title":"PLoS One"},{"issue":"49","key":"10.1016\/j.lansea.2023.100256_bib23","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lansea.2023.100256_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lansea.2023.100256_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.14-0683","article-title":"A\u00a0randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell oral cholera vaccine in Ethiopia","volume":"93","author":"Desai","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lansea.2023.100256_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"2","key":"10.1016\/j.lansea.2023.100256_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tmi.12641","article-title":"Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine\u00a0between endemic and less endemic settings","volume":"21","author":"Desai","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.lansea.2023.100256_bib28","doi-asserted-by":"crossref","first-page":"o2528","DOI":"10.1136\/bmj.o2528","article-title":"Cholera: WHO rations vaccines to preserve stocks amid rising outbreaks","volume":"379","author":"Taylor","year":"2022","journal-title":"BMJ"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:50:57Z","timestamp":1757411457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368223001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":25,"alternative-id":["S2772368223001166"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100256","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100256"}}